Suppr超能文献

细胞因子信号传导中的Mnk激酶与细胞因子反应的调控

Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses.

作者信息

Joshi Sonali, Platanias Leonidas C

机构信息

Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Northwestern University Medical School, and Jesse Brown VA, Medical Center, Chicago, IL ; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

Biomol Concepts. 2012 Apr;3(2):127-139. doi: 10.1515/bmc-2011-0057.

Abstract

The kinases Mnk1 and Mnk2 are activated downstream of the p38 MAPK and MEK/ERK signaling pathways. Extensive work over the years has shown that these kinases control phosphorylation of the eukaryotic initiation factor 4E (eIF4E) and regulate engagement of other effector elements, including hnRNPA1 and PSF. Mnk kinases are ubiquitously expressed and play critical roles in signaling for various cytokine receptors, while there is emerging evidence that they have important functions as mediators of pro-inflammatory cytokine production. In this review the mechanisms of activation of MNK pathways by cytokine receptors are addressed and their roles in diverse cytokine-dependent biological processes are reviewed. The clinical-translational implications of such work and the relevance of future development of specific MNK inhibitors for the treatment of malignancies and auto-immune disorders are discussed.

摘要

激酶Mnk1和Mnk2在p38丝裂原活化蛋白激酶(MAPK)和MEK/细胞外信号调节激酶(ERK)信号通路的下游被激活。多年来的大量研究表明,这些激酶控制真核生物起始因子4E(eIF4E)的磷酸化,并调节包括异质性核糖核蛋白A1(hnRNPA1)和多聚嘧啶序列结合蛋白(PSF)在内的其他效应元件的参与。Mnk激酶在全身广泛表达,在多种细胞因子受体的信号传导中起关键作用,同时越来越多的证据表明它们作为促炎细胞因子产生的介质具有重要功能。在这篇综述中,我们阐述了细胞因子受体激活MNK通路的机制,并综述了它们在多种细胞因子依赖性生物学过程中的作用。我们还讨论了此类研究的临床转化意义,以及未来开发特异性Mnk抑制剂用于治疗恶性肿瘤和自身免疫性疾病的相关性。

相似文献

10

引用本文的文献

1
CRISPR RiPCA for Investigating eIF4E-mGpppX Capped mRNA Interactions.用于研究eIF4E - mGpppX封端mRNA相互作用的CRISPR RiPCA
ACS Chem Biol. 2025 Aug 15;20(8):2038-2048. doi: 10.1021/acschembio.5c00471. Epub 2025 Aug 6.
4
MNK: A Novel Promising Target for Cancer Immunotherapy.MNK:癌症免疫疗法的一个新的有前景的靶点。
Curr Med Chem. 2025;32(17):3347-3365. doi: 10.2174/0109298673260837231120101508.
6
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.克服新型 MNK1 抑制剂的矛盾性激酶引发作用。
J Med Chem. 2022 Apr 28;65(8):6070-6087. doi: 10.1021/acs.jmedchem.1c01941. Epub 2022 Apr 13.
7
Immunotherapies targeting stimulatory pathways and beyond.免疫疗法靶向刺激通路及其他途径。
J Hematol Oncol. 2021 May 12;14(1):78. doi: 10.1186/s13045-021-01085-3.

本文引用的文献

4
Translational control of NKT cell cytokine production by p38 MAPK.p38 MAPK 对 NKT 细胞细胞因子产生的翻译调控。
J Immunol. 2011 Apr 1;186(7):4140-6. doi: 10.4049/jimmunol.1002614. Epub 2011 Mar 2.
7
A meta-analysis of cytokines in Alzheimer's disease.阿尔茨海默病中细胞因子的荟萃分析。
Biol Psychiatry. 2010 Nov 15;68(10):930-41. doi: 10.1016/j.biopsych.2010.06.012. Epub 2010 Aug 8.
8
CCL5 as an adjuvant for cancer immunotherapy.CCL5 作为癌症免疫疗法的佐剂。
Expert Opin Biol Ther. 2010 May;10(5):725-33. doi: 10.1517/14712591003657128.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验